Reta/Cag
Reta/Cag 12.5MG/2.5MG is a research compound designed for scientific studies on weight regulation and metabolic health. It combines Retatrutide, a multi-receptor agonist, with Cagrilintide, an amylin analog. Together, these agents create a dual-pathway model for investigating appetite control, satiety, and energy balance in controlled environments. Researchers value this blend for its ability to show how interconnected hormone signals influence both body weight and metabolism.
In laboratory studies, Retatrutide acts on GLP-1, GIP, and glucagon receptors. This broad activity supports research into glucose regulation, appetite suppression, fat utilization, and overall energy balance.
By contrast, Cagrilintide works through the amylin receptor system, a pathway directly tied to satiety and reduced food intake. When combined, these two agents allow scientists to explore the complementary effects of multi-receptor activity and amylin signaling, offering a modern framework for studying long-term weight management.
Additional areas of research include the compound’s effects on cardiovascular health, insulin response, and energy metabolism. This broad scope makes Reta/Cag 12.5MG/2.5MG a valuable tool for advancing studies in obesity and metabolic science.
Product Care:
Store in a cool, dry place away from light. If reconstituted, Please Refrigerate. For longer term storage, freezing at -20°C is recommended to maintain integrity.
Product Usage:
This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.
Product Note:
All products are shipped in lyphollized or powder form and must be reconstituted to a liquid for research and testing. We are unable to provide any dosing instructions, however all products should be considered pharmaceutical grade.
